Chuang-KuoWuMD
Neurology • Providence, RISpinal Disorder, Vascular Neurology
Associate Professor, Neurology, Texas Tech University Health Science Center School of Medicine
Are you Dr. Wu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 26 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
593 Eddy St
Providence, RI 02903Phone+1 401-444-6788Fax+1 401-444-6912
Summary
- Dr. Chuang-Kuo Wu, MD is a board certified neurologist in Providence, Rhode Island. He is currently licensed to practice medicine in Rhode Island, Texas, and Illinois. He is affiliated with Rhode Island Hospital and is an Associate Professor at Texas Tech University Health Science Center School of Medicine.
Education & Training
Boston University Medical CenterResidency, Neurology, 1998 - 2001- Boston University Medical CenterInternship, Transitional Year, 1997 - 1998
China Medicine UniversityClass of 1988
Certifications & Licensure
RI State Medical License 2003 - 2026
TX State Medical License 2010 - 2026
CA State Medical License 2001 - 2025
MA State Medical License 1999 - 2012
IL State Medical License 2007 - 2011- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Vascular Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Modular EHR, Cerner Corporation, 2013
Publications & Presentations
PubMed
- Pathologically Confirmed Alzheimer's Disease Presenting as Clinical Parkinson's Disease, A Case Report.Nahid Mohammadzadeh, Chuang-Kuo Wu, John E Donahue, Joseph H Friedman
Movement Disorders Clinical Practice. 2024-09-01 - 2 citationsCognitive Complications of COVID-19 Infection.Scott Warren, Jonathan Drake, Chuang-Kuo Wu
Rhode Island Medical Journal. 2022-09-01 - 35 citationsHigher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegenerationNicolai Franzmeier, M. Suárez-Calvet, Lukas Frontzkowski, Annah M. Moore, Timothy J. Hohman
Molecular Neurodegeneration. 2020-10-08
Press Mentions
Two R.I. Hospitals Involved in Global Trial That Found Effective Drug Against Early Alzheimer’sOctober 9th, 2022
Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive PerformanceDecember 2nd, 2019- FDA Fully Approves Alzheimer's Drug LeqembiJuly 14th, 2023
Professional Memberships
- Member
